Cataba­sis Phar­ma­ceu­ti­cals snaps up HAE an­ti­body in buy­out; Glad­stone, UCSF sci­en­tist spear­head launch of neu­ro re­search cen­ter

A few months af­ter fi­nal­ly ad­mit­ting de­feat on their failed Duchenne MD pro­gram, Cataba­sis Phar­ma­ceu­ti­cals is head­ing in a new di­rec­tion with the pur­chase of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER